November 17, 2010 - Titan Pharmaceuticals Presents Phase 3 Probuphine™ Data at Society for Neuroscience Annual Meeting

November 15, 2010 - Titan Pharmaceuticals Announces Third Quarter 2010 Financial Results

October 25, 2010 - Titan Reports Third Quarter 2010 Fanapt® Royalty

October 12, 2010 - Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data

September 28, 2010 - Titan Pharmaceuticals Completes $5 Million Loan

September 22, 2010 - Titan Reports Completion of Patient Enrollment In Phase III Study Of Probuphine™

August 16, 2010 - Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results

August 3, 2010 - Titan Reports Patient Enrollment in Phase III Study of Probuphine™ is Ahead of Schedule

July 26, 2010 - Titan Receives SBIR Grant to Investigate Long Term Treatment For Parkinson's Disease

July 23, 2010 - Titan Reports Second Quarter 2010 Fanapt® Royalty

June 16, 2010 - Probuphine™ patent issued by the U.S. Patent and Trademark Office

May 17, 2010 - Titan Pharmaceuticals announces first quarter 2010 financial results

April 24, 2010 - Titan announces completion of re-registration of the company with the securities and exchange commission

April 21, 2010 - Titan provides estimate of upcoming royalty payment

March 30, 2010 - Titan Initiates Confirmatory Phase 3 Study Of Probuphine™ In The Treatment Of Opioid Addiction

February 3, 2010 - Titan Pharmaceuticals President Sunil Bhonsle to present at the 12th Annual Bio CEO & Investor Conference Monday, February 8, 2010

January 19, 2010 - Titan Pharmaceuticals files FORM 10 for re-registration of the company with the Securities and Exchange Commission